{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": "Treanor_et_al.__2011_",
  "verified_evidence": [
    {
      "id": 1,
      "quote": "The vaccine (Flublok used in this study consisted of purified hemagglutinin (HA) proteins produced in insect cells using baculovirus expression system as previously described [9]. The recombinant HA protein is not cleaved in insect cells and is referred to as rHA0.",
      "supports_claim": true,
      "explanation": "The quote directly states that Flublok is produced by expressing hemagglutinin (HA) proteins in insect cells using a baculovirus expression system. This explicitly supports the claim that Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). No inference is required; the quote provides all necessary details to substantiate the claim.",
      "presence_explanation": "The quote appears on page 2 of the document, with only minor differences in wording and formatting due to OCR cleanup. The relevant passage is: 'The vaccine (Flublok used in this study consisted of puried hemagglutinin (HA) proteins produced in insect cells using baculo virus expression system as previously described [9]. The comb in ant HA protein is not cleaved in insect cells and is fer red to as rHA0.' This matches the quoted content in all essential facts and technical details.",
      "support_explanation": "The quote directly states that Flublok is produced by expressing hemagglutinin (HA) proteins in insect cells using a baculovirus expression system. This explicitly supports the claim that Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). No inference is required; the quote provides all necessary details to substantiate the claim.",
      "original_relevance": "This quote explicitly states that Flublok is produced by expressing hemagglutinin (HA) proteins in insect cells using a baculovirus expression system, directly supporting the claim about its novel production platform."
    },
    {
      "id": 2,
      "quote": "Genes were cloned into baculovirus using RT-PCR from the same CDC derived vaccine seed viruses used for the production of licensed inactivated influenza vaccine for that year.",
      "supports_claim": true,
      "explanation": "The quote directly describes a key step in the baculovirus expression vector system (BEVS): genes (presumably for hemagglutinin, HA) are cloned into baculovirus using RT-PCR, and these genes are derived from the same vaccine seed viruses used for traditional influenza vaccine production. This supports the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using BEVS, as it explicitly details the use of baculovirus for gene expression, which is central to BEVS.",
      "presence_explanation": "The quote appears on page 2 of the document, with only minor formatting differences: 'Genes were cloned into baculo virus using RT-PCR from the same Cd ce rived vaccine seed viruses used for the production of licensed nactivated influenza vaccine for that year.' This matches the quoted content in meaning and technical detail, with only minor OCR artifacts and spacing differences.",
      "support_explanation": "The quote directly describes a key step in the baculovirus expression vector system (BEVS): genes (presumably for hemagglutinin, HA) are cloned into baculovirus using RT-PCR, and these genes are derived from the same vaccine seed viruses used for traditional influenza vaccine production. This supports the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using BEVS, as it explicitly details the use of baculovirus for gene expression, which is central to BEVS.",
      "original_relevance": "This quote details the process of cloning genes into baculovirus, which is a key step in the baculovirus expression vector system (BEVS) used for Flublok production, supporting the claim."
    },
    {
      "id": 3,
      "quote": "HA0 vaccine produced using the baculovirus expression system in healthy adults [9]. These vaccines have been well tolerated at all doses administered, and are associated with low rates of local reactions.",
      "supports_claim": true,
      "explanation": "The quote explicitly states that the HA0 vaccine (which is Flublok, as established elsewhere in the document) is produced using the baculovirus expression system. This directly supports the claim that Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The quote does not mention 'insect cells' in this sentence, but the surrounding context in the document (see page 2: 'The vaccine (Flublok used in this study consisted of puried hemagglutinin (HA) proteins produced in insect cells using baculo virus expression system as previously described [9].') confirms that the baculovirus expression system is used in insect cells. Therefore, the quote, in the context of the document, genuinely supports the claim.",
      "presence_explanation": "The quote appears on page 5 of the document as: 'HA0 vaccine produced using the baculo virus expression system healthy adults [9]. These vaccines have been well tolerated at all doses administered, and are associated with low rates of local reacons.' This matches the quoted content, with only minor differences in spacing and punctuation due to OCR cleanup, but the factual content is preserved.",
      "support_explanation": "The quote explicitly states that the HA0 vaccine (which is Flublok, as established elsewhere in the document) is produced using the baculovirus expression system. This directly supports the claim that Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The quote does not mention 'insect cells' in this sentence, but the surrounding context in the document (see page 2: 'The vaccine (Flublok used in this study consisted of puried hemagglutinin (HA) proteins produced in insect cells using baculo virus expression system as previously described [9].') confirms that the baculovirus expression system is used in insect cells. Therefore, the quote, in the context of the document, genuinely supports the claim.",
      "original_relevance": "This quote confirms that the HA0 vaccine (Flublok) is produced using the baculovirus expression system, directly affirming the claim."
    },
    {
      "id": 4,
      "quote": "The use of recombinant DNA techniques to express proteins in cell culture has been a successful approach for generation of highly effective vaccines for the prevention of hepatitis B (HBV) and human papilloma virus (HPV), and baculovirus expression technology is currently used for a licensed HPV vaccine [26]. Among the available expression technologies, recombinant baculovirus is especially well suited for production of influenza vaccine because the rapidity with which genes can be cloned and inserted into this vector facilitates updating the vaccine at regular intervals. Expression of the HA protein in insect cells using recombinant baculovirus also avoids the need to work with potentially pathogenic, live influenza viruses, and the attendant biocontainment issues that would be a particular concern for production of pandemic vaccines [7]. The results of the current study support the utility of insect cells for the production of well tolerated and effective vaccines for seasonal influenza.",
      "supports_claim": true,
      "explanation": "The quote explicitly describes the use of recombinant baculovirus expression technology to produce HA protein in insect cells for influenza vaccines. This directly supports the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The quote also highlights the advantages of this method and confirms its use in the context of the study, which is about Flublok.",
      "presence_explanation": "The quote appears on page 6 of the document, starting with 'The use of recombinant DNA techniques to express proteins in cell culture has been a successful approach for generation of highly effective vaccines for the prevention of hepatitis B (HBV) and human papilloma virus (HPV), and baculovirus expression technology is currently used for a licensed HPV vaccine [26]. Among the available expression technologies, recombinant baculovirus is especially well suited for production of influenza vaccine because the rapidity with which genes can be cloned and inserted into this vector facilitates updating the vaccine at regular intervals. Expression of the HA protein in insect cells using recombinant baculovirus also avoids the need to work with potentially pathogenic, live influenza viruses, and the attendant biocontainment issues that would be a particular concern for production of pandemic vaccines [7]. The results of the current study support the utility of insect cells for the production of well tolerated and effective vaccines for seasonal influenza.' The content and meaning are preserved, with only minor formatting differences.",
      "support_explanation": "The quote explicitly describes the use of recombinant baculovirus expression technology to produce HA protein in insect cells for influenza vaccines. This directly supports the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The quote also highlights the advantages of this method and confirms its use in the context of the study, which is about Flublok.",
      "original_relevance": "This quote provides a comprehensive explanation of the use of recombinant baculovirus expression in insect cells for producing influenza vaccines like Flublok, directly supporting the claim about the novel production platform."
    },
    {
      "id": "comp_1",
      "quote": "Although embryonated hen's eggs have been used to generate effective influenza vaccines for many years, this system does have several important drawbacks. Vaccine manufacturing using eggs requires specialized facilities, and the ability to scale up egg production, as well as the adaptation of candidate vaccine viruses for growth in eggs, a process that can be time consuming, is not always successful, and which can select receptor variants that may not be optimally representative of circulating influenza strains [1,2]. Expression of proteins in insect cells using recombinant baculovirus has been developed as an alternative approach.",
      "supports_claim": true,
      "explanation": "The quote directly supports the claim. It explicitly contrasts traditional egg-based influenza vaccine production with an alternative method: 'Expression of proteins in insect cells using recombinant baculovirus has been developed as an alternative approach.' This matches the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The document also elsewhere confirms that Flublok uses this method. Therefore, the quote both exists in the document and genuinely supports the claim.",
      "presence_explanation": "The quote appears on the first page of the document, though with some minor OCR-related differences. The relevant passage is: 'Although embryonated hen's eggs have been used to generate effective influenza vaccines for many years, this system does have several important drawbacks. Vaccine manufacturing using eggs requires specialized facilities, and the ability to scale up egg pro growth in eggs, a process that can be time consuming, is not always successful, and which can select receptor variants that may not be optimally representative of circulating influenza strains [1,2]. Expression of proteins in insect cells using recombinant bac-' (the sentence is cut off but continues the same idea as the quote to verify). The factual content and meaning are preserved.",
      "support_explanation": "The quote directly supports the claim. It explicitly contrasts traditional egg-based influenza vaccine production with an alternative method: 'Expression of proteins in insect cells using recombinant baculovirus has been developed as an alternative approach.' This matches the claim that Flublok is produced using a novel platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The document also elsewhere confirms that Flublok uses this method. Therefore, the quote both exists in the document and genuinely supports the claim.",
      "original_relevance": "This quote explicitly states that expression of proteins in insect cells using recombinant baculovirus is an alternative to traditional egg-based influenza vaccine production, directly supporting the claim that Flublok uses a novel platform involving recombinant HA expression in insect cells with baculovirus."
    },
    {
      "id": "comp_2",
      "quote": "Among the available expression technologies, recombinant baculovirus is especially well suited for production of influenza vaccine because the rapidity with which genes can be cloned and inserted into this vector facilitates updating the vaccine at regular intervals. Expression of the HA protein in insect cells using recombinant baculovirus also avoids the need to work with potentially pathogenic, live influenza viruses, and the attendant biocontainment issues that would be a particular concern for production of pandemic vaccines [7].",
      "supports_claim": true,
      "explanation": "The quote explicitly describes the use of recombinant baculovirus for expressing HA protein in insect cells, which matches the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The quote directly supports the claim by stating both the use of recombinant baculovirus and the expression of HA in insect cells, which are the key elements of the BEVS platform used for Flublok.",
      "presence_explanation": "The quote appears on page 6 of the document, in the following passage: 'Among the available expression technologies, recombinant baculovirus is especially well suited for production of influenza vaccine because the rapidity with which genes can be cloned and inserted into this vector facilitates updating the vaccine at regular intervals. Expression of the HA protein in insect cells using recombinant baculovirus also avoids the need to work with potentially pathogenic, live influenza viruses, and the attendant biocontainment issues that would be a particular concern for production of pandemic vaccines [7].' The wording and factual content are semantically equivalent to the quote to verify.",
      "support_explanation": "The quote explicitly describes the use of recombinant baculovirus for expressing HA protein in insect cells, which matches the claim that Flublok is produced using a novel platform where recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS). The quote directly supports the claim by stating both the use of recombinant baculovirus and the expression of HA in insect cells, which are the key elements of the BEVS platform used for Flublok.",
      "original_relevance": "This quote describes the use of recombinant baculovirus for expressing HA protein in insect cells, highlighting its advantages and directly supporting the claim about Flublok's production platform."
    }
  ],
  "verification_stats": {
    "total_verified": 6
  },
  "image_evidence": []
}